About: Sebastiano Mercadante

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Sebastiano Mercadante Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher ORCID ID = 0000-0001-9859-6487

Attributes	Values
rdf:type	Item
description	wetenschapper (nl) дослідник (uk) researcher ORCID ID = 0000-0001-9859-6487 (en)
rdfs:label	Sebastiano Mercadante (en) Sebastiano Mercadante (es) Sebastiano Mercadante (it) Sebastiano Mercadante (nl) Sebastiano Mercadante (sq) Sebastiano Mercadante (ast)
skos:prefLabel	Sebastiano Mercadante (en) Sebastiano Mercadante (es) Sebastiano Mercadante (it) Sebastiano Mercadante (nl) Sebastiano Mercadante (sq) Sebastiano Mercadante (ast)
name	Sebastiano Mercadante (en) Sebastiano Mercadante (es) Sebastiano Mercadante (it) Sebastiano Mercadante (nl) Sebastiano Mercadante (sq) Sebastiano Mercadante (ast)
given name	wds:Q60185302-FB496191-A082-49AA-95C9-DD4E4843CC7C
given name	Sebastiano
instance of	wds:Q60185302-DDD4F221-477B-408A-AA61-27A77B909FFB
instance of	Homo sapiens
occupation	wds:Q60185302-DF5CDEB2-782A-408C-8295-248013B675E2
NUKAT ID	wds:q60185302-82e24831-4a9d-056e-2cde-07a84afac80c
Parsifal cluster ID	wds:Q60185302-7B48CAAB-987E-4A81-88BF-A7C8AAD899B8
place of birth	wds:Q60185302-3368b7a7-495f-6776-2021-8e528f95b7bd
sex or gender	wds:Q60185302-898F0132-FB3D-4B48-AD9D-BC418A952011
VIAF ID	wds:Q60185302-FA080453-23C5-4824-8BD0-08C71280AF72
SBN author ID	wds:Q60185302-C6C84C76-4C73-4D45-8064-8EE3A681E748
date of birth	wds:Q60185302-A2ECA51A-6138-4786-B441-5BF9ED9AEBE8
educated at	wds:Q60185302-59AD6E93-9FC5-433C-AD30-503277C43A23
PLWABN ID	wds:Q60185302-24237607-B86E-4037-9034-3952A1C25F13
family name	wds:Q60185302-DF7A784A-B2BC-4BEA-A384-5E9310F677D8
WorldCat Identities ID (superseded)	wds:Q60185302-EFD7DCA7-CB16-4965-8DFB-79BF238DDB95
VIAF ID	http://viaf.org/viaf/313518334
occupation	director
NUKAT ID	n2016231018
Parsifal cluster ID	435096
place of birth	San Cataldo
sex or gender	male
VIAF ID	313518334
SBN author ID	SBLV264303
date of birth	1955-01-01 00:00:00Z (xsd:dateTime)
educated at	University of Palermo
PLWABN ID	9810701681105606
family name	Mercadante
WorldCat Identities ID (superseded)	viaf-313518334
ORCID iD	wds:Q60185302-174E1835-206F-4E1F-A3E6-CED4D48AC77E
ORCID iD	https://orcid.org/0000-0001-9859-6487
ORCID iD	0000-0001-9859-6487
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q60185302
is author of	Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care Current knowledge of buprenorphine and its unique pharmacological profile Effectiveness and tolerability of amidotrizoate for the treatment of constipation resistant to laxatives in advanced cancer patients Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients Effects of red blood cell transfusion on anemia-related symptoms in patients with cancer Controlled sedation for refractory symptoms in dying patients Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Management of painful bone metastases Cancer pain Patients' and relatives' perceptions about intravenous and subcutaneous hydration The use of high doses of OROS hydromorphone in an acute palliative care unit Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review Low morphine doses in opioid-naive cancer patients with pain Surgical treatment of early breast cancer in day surgery. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids Managing breakthrough pain Octreotide for malignant bowel obstruction: twenty years after Pain in patients with lung cancer: pathophysiology and treatment Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS) The use of rapid onset opioids for breakthrough cancer pain: the challenge of its dosing The use of opioids for treatment of cancer pain Breakthrough pain in cancer patients: prevalence, mechanisms and treatment options Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group From "Breakthrough" to "Episodic" Cancer Pain? A European Association for Palliative Care Research Network Expert Delphi Survey Toward a Common Terminology and Classification of Transient Cancer Pain Exacerbations Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies The use of opioids for breakthrough pain in acute palliative care unit by using doses proportional to opioid basal regimen Breakthrough pain in advanced cancer patients followed at home: a longitudinal study Prevalence and treatment of cancer pain in Italian oncological wards centres: a cross-sectional survey Combined oral prolonged-release oxycodone and naloxone in chronic pain management Opioid titration in cancer pain: a critical review Opioid switching in cancer pain: From the beginning to nowadays Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review Opioid switching in patients with advanced cancer followed at home. A retrospective analysis Hyperalgesia: an emerging iatrogenic syndrome Opioid switching: a systematic and critical review Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit Pharmacotherapy for breakthrough cancer pain Episodic (Breakthrough) Pain Prevalence in a Population of Cancer Pain Patients. Comparison of Clinical Diagnoses With the QUDEI—Italian Questionnaire for Intense Episodic Pain The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting Intravenous morphine for management of cancer pain Managing difficult pain conditions in the cancer patient Ketamine: to be or not to be.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software